The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene?
PLoS Genet
.
2017 Jan 12;13(1):e1006505.
doi: 10.1371/journal.pgen.1006505.
eCollection 2017 Jan.
Authors
Alexander Arthur Wurm
1
,
Daniel G Tenen
2
3
,
Gerhard Behre
1
Affiliations
1
Division of Hematology and Oncology, Leipzig University Hospital, Leipzig, Germany.
2
Cancer Science Institute, National University of Singapore, Singapore.
3
Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
PMID:
28081132
PMCID:
PMC5230742
DOI:
10.1371/journal.pgen.1006505
No abstract available
Publication types
Comment
MeSH terms
Genes, Tumor Suppressor
Hematopoiesis
Humans
Leukemia, Myeloid, Acute*
Macrophages
MicroRNAs
Monocytes*
Substances
MIRN22 microRNA, human
MicroRNAs
Grants and funding
P01 HL131477/HL/NHLBI NIH HHS/United States
R01 DK103858/DK/NIDDK NIH HHS/United States
R35 CA197697/CA/NCI NIH HHS/United States